Impact of the Crohn's-like lymphoid reaction on staging of right-sided colon cancer: results of multivariate analysis.
The presence of lymphoid aggregates within the muscularis propria or pericolic fibroadipose tissue apposing invasive colorectal carcinoma, termed the Crohn's-like lymphoid reaction, has been related to improved patient length of survival according to univariate statistical analysis. We tested the Crohn's-like lymphoid reaction as an indicator of prognosis in a multivariate statistical analysis of 344 resected right-sided colonic cancers. Improved 5-year survival in univariate analysis was associated with low tumor grade, regular tubule configuration, expanding tumor growth pattern, prominent peritumoral lymphocytic infiltration, absence of tumoral invasion of extramural veins, all levels of intramural and extramural invasion short of widespread local tumor permeation, conspicuous Crohn's-like lymphoid reaction, and absence of both nodal metastasis and nodal-independent tumor nodules in pericolic fat. By the Cox proportional hazard model using the stepwise method, depth of tumor invasion, lymph node metastasis, Crohn's-like lymphoid reaction, and metastatic tumor nodules in pericolic fat retained independent prognostic significance. Combining the four variables to formulate pathological prognostic categories yielded a highly favorable prognostic group-92% 5-year survival and 95% confidence limits (88% to 96%)--encompassing 53% of the study population. It included all Dukes' stage A carcinomas, 66% of Dukes' stage B adenocarcinomas, and 11% of Dukes' stage C cancers. Lymph node metastases coupled with intramural and extramural extent of tumor invasion are the cornerstones of colorectal cancer staging. Addition of other variables improves prognostication for the cecum and ascending colon. From this study the Crohn's-like lymphoid reaction and metastatic tumor nodules in pericolic fat emerge as significant independent indicators of prognosis for right-sided colon cancer. Complex correlations of both indicators with nonselected variables were observed.
Harrison
J C
JC
Pathology Associates, P.A., Huntsville, AL.
Dean
P J
PJ
el-Zeky
F
F
Vander Zwaag
R
R
D000230:Adenocarcinoma / Q000276:immunology / Q000473:pathology* / Q000556:secondary; D000273:Adipose Tissue / Q000473:pathology; D002449:Cell Aggregation; D003106:Colon / Q000276:immunology / Q000473:pathology*; D003110:Colonic Neoplasms / Q000276:immunology / Q000401:mortality / Q000473:pathology*; D003424:Crohn Disease / Q000473:pathology*; D006801:Humans; D008221:Lymphoid Tissue / Q000473:pathology*; D015999:Multivariate Analysis; D009130:Muscle, Smooth / Q000473:pathology; D009367:Neoplasm Staging; D011379:Prognosis; D016016:Proportional Hazards Models; D016019:Survival Analysis